Your browser doesn't support javascript.
loading
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
El Osta, Badi; Behera, Madhusmita; Kim, Sungjin; Berry, Lynne D; Sica, Gabriel; Pillai, Rathi N; Owonikoko, Taofeek K; Kris, Mark G; Johnson, Bruce E; Kwiatkowski, David J; Sholl, Lynette M; Aisner, Dara L; Bunn, Paul A; Khuri, Fadlo R; Ramalingam, Suresh S.
Afiliação
  • El Osta B; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Behera M; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Kim S; Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California.
  • Berry LD; Center for Quantitative Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Sica G; Department of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Pillai RN; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Owonikoko TK; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Kris MG; Department of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Johnson BE; Lung Cancer Program, Dana-Farber Harvard Cancer Center, Boston, Massachusetts.
  • Kwiatkowski DJ; Lung Cancer Program, Dana-Farber Harvard Cancer Center, Boston, Massachusetts.
  • Sholl LM; Lung Cancer Program, Dana-Farber Harvard Cancer Center, Boston, Massachusetts.
  • Aisner DL; Department of Pathology, University of Colorado Denver School of Medicine, Aurora, Colorado.
  • Bunn PA; Division of Medical Oncology, University of Colorado Denver School of Medicine, Aurora, Colorado.
  • Khuri FR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: ssramal@emory.edu.
J Thorac Oncol ; 14(5): 876-889, 2019 05.
Article em En | MEDLINE | ID: mdl-30735816
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Geórgia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Geórgia País de publicação: Estados Unidos